No Photo Available

Last Update

2010-01-14T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Richard Guarino?

Dr. Richard A. Guarino

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Background Information

Employment History

President

Oxford Pharmaceutical Resources , Inc.

President

Oxford Pharmaceutical Services Inc

President and Chief Executive Officer

Oxford Research International Corp.

Vice President and Medical Director

Revlon Healthcare Group

Director of Clinical Research

Sandoz Inc

Education

MD

M.D.

Web References (17 Total References)


Dr. Richard A. Guarino, ...

www.hum-molgen.org [cached]

Dr. Richard A. Guarino, President, Oxford Pharmaceutical Resources, Inc.


By Richard Guarino, Oxford ...

www.informahealthcarebooks.com [cached]

By Richard Guarino, Oxford Pharmaceutical Resources, Totowa, New Jersey, USA

...
Richard Guarino is President of Oxford Pharmaceuticals, Inc., and was the former CEO of Oxford Research International Corp. He is the editor of Informa Healthcare's Fourth Edition of New Drug Approval Process, the first book to guide and recommend ways to expedite global new drug approval processes while also following meeting federal and industry requirements. Dr. Guarino is a member of the Lupus Erythematosus Foundation, the Cystic Fibrosis Foundation and the Columbus Foundation, Drug Information Association, Association of Clinical Research Professionals, and the Academy of Pharmaceutical Physicians and Investigators.


Dr. Richard A. Guarino; President, ...

www.hum-molgen.org [cached]

Dr. Richard A. Guarino; President, Oxford Pharmaceutical Resources, Inc.

Richard A. Guarino, M.D. is President of Oxford Pharmaceutical Resources, Inc. a consulting organization specializing in the planning, implementing and submitting of INDs, NDAs and CTDs.Dr. Guarino also has 25 years of experience in new drug applications, in marketing launches, advertising, and FDA liaison.
Dr. Guarino was formerly the President and CEO of Oxford Research International Corp. one of the largest CROs in the United States.Besides serving as an adjunct professor at Fairleigh Dickinson University, he was a former Director of Clinical Research at Sandoz Pharmaceutical Inc., now Novartis, and held the position of Vice President/Medical Director at Revlon Healthcare Group.He has been acclaimed for his book, New Drug Approval Process, now in its 4th edition.It is the first book ever written to guide and recommend ways to expedite global new drug approval process while following all the requirements of the Code of Federal Regulations and EU Directives.
Dr. Guarino is a member of many professional societies and associations including the New Jersey and New York Academies of Medicine, The Royal Society of Medicine, the Columbus Citizens Foundation, the Presidential Advisory Cabinet at Fairleigh Dickinson University, the Lupus Erythematosus Foundation, the Cystic Fibrosis Foundation and the Columbus Foundation, Drug Information Association (DIA), Association of Clinical Research Professionals (ACRP), and Academy of Pharmaceutical Physicians and Investigators (APPI).


Richard A. Guarino, MD; ...

www.cfpa.com [cached]

Richard A. Guarino, MD; President, Oxford Pharmaceutical Resources, Inc.

Dr. Richard A. Guarino is President of Oxford Pharmaceutical Resources, Inc., a Consulting Clinical and Regulatory Organization specializing in the planning, implementing and submitting INDs, NDAs, in the CTDs format. Dr, Guarino has 35 years of experience in new drug applications, marketing launches, pharmaceutical and product advertising, and FDA Liaison. He was formerly the President and CEO of Oxford Research International Corp. one of the largest CRO's in the United States. Besides serving as an adjunct professor at Fairleigh Dickinson University, he was a former Director of Clinical Research at Sandoz Pharmaceutical Inc, (Novartis) and held the position of Vice President/Medical Director at Revlon Healthcare Group. He has been acclaimed for his book, New Drug Approval Process, now in its 5th edition. It is the first book ever written to guide and recommend ways to expedite the new drug approval process while following all the requirements of the US Code of Federal Regulations, EU Directives and ICH Guidelines.
Dr. Guarino is a member of many professional societies and associations including the New Jersey and New York Academies of Medicine, The Royal Society of Medicine, the Columbus Citizens Foundation, the Presidential Advisory Cabinet at Fairleigh Dickinson University, the Lupus Erythematosus Foundation, the Cystic Fibrosis Foundation and the Sovereign Military Hospitaller Order of Saint John of Jerusalem of Rhodes and of Malta American Association, USA Drug Information Association (DIA), Association of Clinical Research Professionals (ACRP), and Academy of Pharmaceutical Physicians and Investigators (APPI).


Richard A. Guarino, MD; ...

www.cfpa.com [cached]

Richard A. Guarino, MD; President, Oxford Pharmaceutical Resources, Inc.

Dr. Richard A. Guarino is President of Oxford Pharmaceutical Resources, Inc., a Consulting Clinical and Regulatory Organization specializing in the planning, implementing and submitting INDs, NDAs, in the CTDs format. Dr, Guarino has 35 years of experience in new drug applications, marketing launches, pharmaceutical and product advertising, and FDA Liaison. He was formerly the President and CEO of Oxford Research International Corp. one of the largest CRO's in the United States. Besides serving as an adjunct professor at Fairleigh Dickinson University, he was a former Director of Clinical Research at Sandoz Pharmaceutical Inc, (Novartis) and held the position of Vice President/Medical Director at Revlon Healthcare Group. He has been acclaimed for his book, New Drug Approval Process, now in its 5th edition. It is the first book ever written to guide and recommend ways to expedite the new drug approval process while following all the requirements of the US Code of Federal Regulations, EU Directives and ICH Guidelines.
Dr. Guarino is a member of many professional societies and associations including the New Jersey and New York Academies of Medicine, The Royal Society of Medicine, the Columbus Citizens Foundation, the Presidential Advisory Cabinet at Fairleigh Dickinson University, the Lupus Erythematosus Foundation, the Cystic Fibrosis Foundation and the Sovereign Military Hospitaller Order of Saint John of Jerusalem of Rhodes and of Malta American Association, USA Drug Information Association (DIA), Association of Clinical Research Professionals (ACRP), and Academy of Pharmaceutical Physicians and Investigators (APPI).

Similar Profiles

Other People with this Name

Other people with the name Guarino

Gaetano Guarino
Crionet srl

Joseph Guarino
Samaritan Village Inc

Jeffrey Guarino
DE Title Services LLC

Laura Guarino
SalusCare Inc

Michelle Guarino
The Bank of New York Company , Inc.

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory